Split History
ETFs Holding CERE »    CERE Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. According to our CERE split history records, Cerevel Therapeutics Holdings has had 1 split.
CERE split history picture
Cerevel Therapeutics Holdings (CERE) has 1 split in our CERE split history database. The split for CERE took place on April 09, 2015. This was a 1 for 8 reverse split, meaning for each 8 shares of CERE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.

When a company such as Cerevel Therapeutics Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CERE split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cerevel Therapeutics Holdings shares, starting with a $10,000 purchase of CERE, presented on a split-history-adjusted basis factoring in the complete CERE split history. CERE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/31/2020
End date: 05/17/2024
Start price/share: $11.20
End price/share: $42.10
Dividends collected/share: $0.00
Total return: 275.89%
Average Annual Total Return: 41.72%
Starting investment: $10,000.00
Ending investment: $37,585.77
Years: 3.80
Date Ratio
04/09/20151 for 8
CERE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CERU Split History
CFMS Split History
CFRX Split History
CGIX Split History
CGNT Split History
CHDX Split History
CHE Split History
CHFS Split History
CHRS Split History
CIVI Split History

Email EnvelopeFree CERE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
Chimera Investment Corporation (CIM)
Advent Technologies Holdings, Inc. (ADN)
Telesis Bio Inc. (TBIO)
United States Lime & Minerals, Inc. (USLM)
Inspire Veterinary Partners, Inc. (IVP)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CERE Insider Buying

CERE Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.